These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 33965795)

  • 1. Mitigation policies, community mobility, and COVID-19 case counts in Australia, Japan, Hong Kong, and Singapore.
    Hakim AJ; Victory KR; Chevinsky JR; Hast MA; Weikum D; Kazazian L; Mirza S; Bhatkoti R; Schmitz MM; Lynch M; Marston BJ
    Public Health; 2021 May; 194():238-244. PubMed ID: 33965795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of travel ban implementation on COVID-19 spread in Singapore, Taiwan, Hong Kong and South Korea during the early phase of the pandemic: a comparative study.
    Gwee SXW; Chua PEY; Wang MX; Pang J
    BMC Infect Dis; 2021 Aug; 21(1):799. PubMed ID: 34380452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to organise travel restrictions in the new future: lessons from the COVID-19 response in Hong Kong and Singapore.
    Lai D; Cai Y; Chan TH; Gan D; Hurson AN; Zhang YD
    BMJ Glob Health; 2022 Feb; 7(2):. PubMed ID: 35228258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of Government-Mandated Closures and Restrictions With Aggregate Mobility Trends and SARS-CoV-2 Infections in Nigeria.
    Erim DO; Oke GA; Adisa AO; Odukoya O; Ayo-Yusuf OA; Erim TN; Tsafa TN; Meremikwu MM; Agaku IT
    JAMA Netw Open; 2021 Jan; 4(1):e2032101. PubMed ID: 33471117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Public acceptability of COVID-19 control measures in Singapore, Hong Kong, and Malaysia: A cross-sectional survey.
    Voo TC; Ballantyne A; Ng CJ; Cowling BJ; Xiao J; Phang KC; Kaur S; Jenarun G; Kumar V; Lim JM; Tun ZM; Wong NCB; Tam CC
    Int J Infect Dis; 2022 Jul; 120():51-58. PubMed ID: 35430376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using volunteered geographic information to assess mobility in the early phases of the COVID-19 pandemic: a cross-city time series analysis of 41 cities in 22 countries from March 2nd to 26th 2020.
    Vannoni M; McKee M; Semenza JC; Bonell C; Stuckler D
    Global Health; 2020 Sep; 16(1):85. PubMed ID: 32967691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early public adherence with and support for stay-at-home COVID-19 mitigation strategies despite adverse life impact: a transnational cross-sectional survey study in the United States and Australia.
    Czeisler MÉ; Howard ME; Robbins R; Barger LK; Facer-Childs ER; Rajaratnam SMW; Czeisler CA
    BMC Public Health; 2021 Mar; 21(1):503. PubMed ID: 33722226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early social distancing policies in Europe, changes in mobility & COVID-19 case trajectories: Insights from Spring 2020.
    Woskie LR; Hennessy J; Espinosa V; Tsai TC; Vispute S; Jacobson BH; Cattuto C; Gauvin L; Tizzoni M; Fabrikant A; Gadepalli K; Boulanger A; Pearce A; Kamath C; Schlosberg A; Stanton C; Bavadekar S; Abueg M; Hogue M; Oplinger A; Chou K; Corrado G; Shekel T; Jha AK; Wellenius GA; Gabrilovich E
    PLoS One; 2021; 16(6):e0253071. PubMed ID: 34191818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inferring super-spreading from transmission clusters of COVID-19 in Hong Kong, Japan, and Singapore.
    Kwok KO; Chan HHH; Huang Y; Hui DSC; Tambyah PA; Wei WI; Chau PYK; Wong SYS; Tang JWT
    J Hosp Infect; 2020 Aug; 105(4):682-685. PubMed ID: 32446721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The shift of percent excess mortality from zero-COVID policy to living-with-COVID policy in Singapore, South Korea, Australia, New Zealand and Hong Kong SAR.
    Cao X; Li Y; Zi Y; Zhu Y
    Front Public Health; 2023; 11():1085451. PubMed ID: 37020822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Policy disparities in fighting COVID-19 among Japan, Italy, Singapore and China.
    Wang X; Shi L; Zhang Y; Chen H; Sun G
    Int J Equity Health; 2021 Jan; 20(1):33. PubMed ID: 33441144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.
    Boon SS; Wong MCS; Ng RWY; Leung DTM; Chen Z; Lai CKC; Ho WCS; Huang J; Wong BKC; Fung KSC; Chan PKS
    JAMA Netw Open; 2021 Nov; 4(11):e2132923. PubMed ID: 34779848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of mass gatherings on the local transmission of COVID-19 and the implications for social distancing policies: Evidence from Hong Kong.
    Zhu P; Tan X; Wang M; Guo F; Shi S; Li Z
    PLoS One; 2023; 18(2):e0279539. PubMed ID: 36724151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Navigating from SARS-CoV-2 elimination to endemicity in Australia, Hong Kong, New Zealand, and Singapore.
    De Foo C; Grépin KA; Cook AR; Hsu LY; Bartos M; Singh S; Asgari N; Teo YY; Heymann DL; Legido-Quigley H
    Lancet; 2021 Oct; 398(10311):1547-1551. PubMed ID: 34619099
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of physical distancing policy on reducing transmission of SARS-CoV-2 globally: Perspective from government's response and residents' compliance.
    Chung PC; Chan TC
    PLoS One; 2021; 16(8):e0255873. PubMed ID: 34375342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study.
    Cowling BJ; Ali ST; Ng TWY; Tsang TK; Li JCM; Fong MW; Liao Q; Kwan MY; Lee SL; Chiu SS; Wu JT; Wu P; Leung GM
    Lancet Public Health; 2020 May; 5(5):e279-e288. PubMed ID: 32311320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with COVID-19 vaccination intent in Singapore, Australia and Hong Kong.
    Shah S; Gui H; Chua PEY; Tan JB; Suen LK; Chan SW; Pang J
    Vaccine; 2022 May; 40(21):2949-2959. PubMed ID: 35414417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age, source, and future risk of COVID-19 infections in two settings of Hong Kong and Singapore.
    Zhu S; Tao J; Gao H; He D
    BMC Res Notes; 2020 Jul; 13(1):336. PubMed ID: 32660556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A tale of two city-states: A comparison of the state-led vs civil society-led responses to COVID-19 in Singapore and Hong Kong.
    Yuen S; Cheng EW; Or NHK; Grépin KA; Fu KW; Yung KC; Yue RPH
    Glob Public Health; 2021; 16(8-9):1283-1303. PubMed ID: 33592151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 impacts on cross-border mobility of senior population between Shenzhen and Hong Kong.
    He S; Niu C; Wei Y; Cai Y; Zhang W; Xiao Y; Yin J
    Front Public Health; 2023; 11():1285288. PubMed ID: 38054075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.